Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

495 ARTÍCULOS , VIENDO DEL 196 AL 210

Technology in Parkinson's disease: Challenges and opportunities

Espay AJ, Bonato P, Nahab FB, Maetzler W, Dean JM, Klucken J, Eskofier BM, Merola A, Horak F, Lang AE, Reilmann R, Giuffrida J, Nieuwboer A, Horne M, Little MA, Litvan I, Simuni T, Dorsey ER, Burack MA, Kubota K, Kamondi A, Godinho C, Daneault JF, Mitsi G, Krinke L, Hausdorff JM, Bloem BR, Papapetropoulos S; Movement Disorders Society Task Force on Technology.

Mov Disord. 2016 Sep;31(9):1272-82. doi: 10.1002/mds.26642. Epub 2016 Apr 29.

Prevalence of anxiety in Parkinson's disease: A systematic review and meta-analysis

Broen MP, Narayen NE, Kuijf ML, Dissanayaka NN, Leentjens AF.

Mov Disord. 2016 Aug;31(8):1125-33. doi: 10.1002/mds.26643. Epub 2016 Apr 29.

Neuromodulation for restoring memory

Bick SK, Eskandar EN.

Neurosurg Focus. 2016 May;40(5):E5. doi: 10.3171/2016.3.FOCUS162.

Oral r-(-)-11-o-valeryl-n-n-propylnoraporphine reverses motor deficits in mptp-treated marmosets

Lincoln L, Fisher R, Jackson MJ, Jenner P, Neumeyer J, Sromek AW, Lees AJ, Rose S.

Mov Disord. 2016 Sep;31(9):1381-8. doi: 10.1002/mds.26626. Epub 2016 May 2.

Mutation in ADORA1 identified as likely cause of early-onset parkinsonism and cognitive dysfunction

Jaberi E, Rohani M, Shahidi GA, Nafissi S, Arefian E, Soleimani M, Moghadam A, Arzenani MK, Keramatian F, Klotzle B, Fan JB, Turk C, Steemers F, Elahi E.

Mov Disord. 2016 Jul;31(7):1004-11. doi: 10.1002/mds.26627. Epub 2016 May 2.

Protein biomarkers in Parkinson's disease: Focus on cerebrospinal fluid markers and synaptic proteins

Halbgebauer S, Öckl P, Wirth K, Steinacker P, Otto M.

Mov Disord. 2016 Jun;31(6):848-60. doi: 10.1002/mds.26635. Epub 2016 May 2.

Cerebrospinal fluid biomarkers in Alzheimer's and Parkinson's diseases-From pathophysiology to clinical practice

Blennow K, Biscetti L, Eusebi P, Parnetti L.

Mov Disord. 2016 Jun;31(6):836-47. doi: 10.1002/mds.26656. Epub 2016 May 4.

Nutraceuticals in Parkinson's Disease

Hang L, Basil AH, Lim KL.

Neuromolecular Med. 2016 Sep;18(3):306-21. doi: 10.1007/s12017-016-8398-6. Epub 2016 May 4.

Optimizing odor identification testing as quick and accurate diagnostic tool for Parkinson's disease

Mahlknecht P, Pechlaner R, Boesveldt S, Volc D, Pinter B, Reiter E, Müller C, Krismer F, Berendse HW, van Hilten JJ, Wuschitz A, Schimetta W, Högl B, Djamshidian A, Nocker M, Göbel G, Gasperi A, Kiechl S, Willeit J, Poewe W, Seppi K.

Mov Disord. 2016 Sep;31(9):1408-13. doi: 10.1002/mds.26637. Epub 2016 May 9.

Low-frequency deep brain stimulation for Parkinson's disease: Great expectation or false hope?

di Biase L, Fasano A.

Mov Disord. 2016 Jul;31(7):962-7. doi: 10.1002/mds.26658. Epub 2016 May 13.

Transcranial direct current stimulation lessens dual task cost in people with Parkinson's disease

Swank C, Mehta J, Criminger C.

Neurosci Lett. 2016 Jul 28;626:1-5. doi: 10.1016/j.neulet.2016.05.010. Epub 2016 May 13.

Early-onset parkinsonism due to compound heterozygous POLG mutations

Rempe T, Kuhlenbäumer G, Krüger S, Biskup S, Matschke J, Hagel C, Deuschl G, van Eimeren T.

Parkinsonism Relat Disord. 2016 Aug;29:135-7. doi: 10.1016/j.parkreldis.2016.04.020. Epub 2016 Apr 27.

Early synaptic dysfunction in Parkinson's disease: Insights from animal models

Schirinzi T, Madeo G, Martella G, Maltese M, Picconi B, Calabresi P, Pisani A.

Mov Disord. 2016 Jun;31(6):802-13. doi: 10.1002/mds.26620. Epub 2016 May 19.

Disability Rating Scales in Parkinson's Disease: Critique and Recommendations

Shulman LM, Armstrong M, Ellis T, Gruber-Baldini A, Horak F, Nieuwboer A, Parashos S, Post B, Rogers M, Siderowf A, Goetz CG, Schrag A, Stebbins GT, Martinez-Martin P.

Mov Disord. 2016 Oct;31(10):1455-1465. doi: 10.1002/mds.26649.

Biomarkers for dementia and mild cognitive impairment in Parkinson's disease

Delgado-Alvarado M, Gago B, Navalpotro-Gomez I, Jiménez-Urbieta H, Rodriguez-Oroz MC.

Mov Disord. 2016 Jun;31(6):861-81. doi: 10.1002/mds.26662. Epub 2016 May 19.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias